A comparison of depth of necrosis among adjuvant therapies used for the treatment of benign bone tumors.
Brenden BombardierDouglas HaaseKyle SweeneyElizabeth FriedmanTanner PoppeNicole HughesPublished in: Journal of surgical oncology (2021)
This study confirms, through histologic analysis, adjuvant therapies create a rim of cellular necrosis beyond that of burring during extended curettage, supporting their use in the treatment of benign bone tumors. Furthermore, it provides a head-to-head comparison.